Title : TACE plus sorafenib for the treatment of hepatocellular carcinoma: results of the multicenter, phase II SOCRATES trial.

Pub. Date : 2014 Nov

PMID : 25173458






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sorafenib was given at a dose of 400 mg/bid (interrupted only around TACE). Sorafenib ADAM metallopeptidase domain 17 Homo sapiens